Johnson & Johnson Innovation - Jjdc, Inc. - Net Worth and Insider Trading
Johnson & Johnson Innovation - Jjdc, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Johnson & Johnson Innovation - Jjdc, Inc. owns 15 companies in total, including Fusion Pharmaceuticals Inc (FUSN) , Provention Bio Inc (PRVB) , and Inspire Medical Systems Inc (INSP) among others .
Insider Ownership Summary of Johnson & Johnson Innovation - Jjdc, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FUSN | Fusion Pharmaceuticals Inc | 2020-06-25 | 10 percent owner |
| PRVB | Provention Bio Inc | 2018-07-03 | 10 percent owner |
| INSP | Inspire Medical Systems Inc | 2018-05-02 | 10 percent owner |
 | | 2017-11-20 | 10 percent owner |
| | 2014-07-07 | 10 percent owner |
| | 2016-08-10 | 10 percent owner |
| | 2014-11-05 | 10 percent owner |
| | 2014-03-06 | 10 percent owner |
| | 2014-05-01 | 10 percent owner |
| | 2014-02-04 | 10 percent owner |
| | 2010-12-31 | 10 percent owner |
| | 2010-04-14 | 10 percent owner |
| | 2023-09-15 | 10 percent owner |
| | 2022-11-09 | 10 percent owner |
| | 2014-02-04 | 10 percent owner |
Johnson & Johnson Innovation - Jjdc, Inc. Trading Performance
Johnson & Johnson Innovation - Jjdc, Inc. Ownership Network
Ownership Network List of Johnson & Johnson Innovation - Jjdc, Inc.
Ownership Network Relation of Johnson & Johnson Innovation - Jjdc, Inc.
Johnson & Johnson Innovation - Jjdc, Inc. Owned Company Details
What does Fusion Pharmaceuticals Inc do?
Who are the key executives at Fusion Pharmaceuticals Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Fusion Pharmaceuticals Inc. Other key executives at Fusion Pharmaceuticals Inc include Chief Medical Officer Dmitri Bobilev , director & Chief Executive Officer John Valliant , and Chief Scientific Officer Christopher P Leamon .
Fusion Pharmaceuticals Inc (FUSN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Fusion Pharmaceuticals Inc (FUSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fusion Pharmaceuticals Inc (FUSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Fusion Pharmaceuticals Inc (FUSN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fusion Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Provention Bio Inc do?
Who are the key executives at Provention Bio Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Provention Bio Inc. Other key executives at Provention Bio Inc include 10 percent owner Sessa Capital (master), L.p. , director & 10 percent owner & Chief Scientific Officer Francisco Leon , and director & 10 percent owner & President and CEO Ashleigh Palmer .
Provention Bio Inc (PRVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Provention Bio Inc (PRVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Provention Bio Inc (PRVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Provention Bio Inc (PRVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Provention Bio Inc Insider Transactions
- Download to Excel(.xls)
What does Inspire Medical Systems Inc do?
Who are the key executives at Inspire Medical Systems Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Inspire Medical Systems Inc. Other key executives at Inspire Medical Systems Inc include Chief Technology Officer John Rondoni , Senior VP. & Sales & Marketing Randy Ban , and Chief Financial Officer Richard Buchholz .
Inspire Medical Systems Inc (INSP) Insider Trades Summary
Over the past 18 months, Johnson & Johnson Innovation - Jjdc, Inc. made no insider transaction in Inspire Medical Systems Inc (INSP). Other recent insider transactions involving Inspire Medical Systems Inc (INSP) include a net sale of 8,042 shares made by Jerry C Griffin , a net sale of 26,726 shares made by John Rondoni , and a net sale of 127,992 shares made by Timothy P. Herbert .
In summary, during the past 3 months, insiders sold 35,534 shares of Inspire Medical Systems Inc (INSP) in total and bought 0 shares, with a net sale of 35,534 shares. During the past 18 months, 214,850 shares of Inspire Medical Systems Inc (INSP) were sold and 100 shares were bought by its insiders, resulting in a net sale of 214,750 shares.
Inspire Medical Systems Inc (INSP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inspire Medical Systems Inc Insider Transactions
- Download to Excel(.xls)
What does Achillion Pharmaceuticals Inc do?
Who are the key executives at Achillion Pharmaceuticals Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Commercial Officer Paul E Firuta , EVP & Chief Medical Officer Steven Zelenkofske , and General Counsel Martha E Manning .
Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Achillion Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Minerva Neurosciences Inc do?
Who are the key executives at Minerva Neurosciences Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Minerva Neurosciences Inc. Other key executives at Minerva Neurosciences Inc include 10 percent owner Ag Boehringer , 10 percent owner Boehringer Ingelheim International Gmbh , and EVP and Head of R&D Remy Luthringer .
Minerva Neurosciences Inc (NERV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Minerva Neurosciences Inc (NERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Neurosciences Inc (NERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Minerva Neurosciences Inc (NERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Minerva Neurosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Protagonist Therapeutics Inc do?
Who are the key executives at Protagonist Therapeutics Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Financial Officer Asif Ali , director & President and CEO Patel Dinesh V Ph D , and Chief Development Officer Suneel Gupta .
Protagonist Therapeutics Inc (PTGX) Insider Trades Summary
Over the past 18 months, Johnson & Johnson Innovation - Jjdc, Inc. made no insider transaction in Protagonist Therapeutics Inc (PTGX). Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 165,000 shares made by Patel Dinesh V Ph D , a net sale of 36,975 shares made by William D. Waddill , and a net sale of 39,624 shares made by Asif Ali .
In summary, during the past 3 months, insiders sold 22,203 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 22,203 shares. During the past 18 months, 248,447 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 248,447 shares.
Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protagonist Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Nevro Corp do?
Who are the key executives at Nevro Corp?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Nevro Corp. Other key executives at Nevro Corp include Chief Commercial Officer Greg Siller , President & CEO Kevin R Thornal , and Chief Accounting Officer Richard B. Carter .
Nevro Corp (NVRO) Insider Trades Summary
Over the past 18 months, Johnson & Johnson Innovation - Jjdc, Inc. made no insider transaction in Nevro Corp (NVRO). Other recent insider transactions involving Nevro Corp (NVRO) include a net purchase of 7,500 shares made by Shawn Mccormick ,
In summary, during the past 3 months, insiders sold 0 shares of Nevro Corp (NVRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nevro Corp (NVRO) were sold and 7,500 shares were bought by its insiders, resulting in a net purchase of 7,500 shares.
Nevro Corp (NVRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nevro Corp Insider Transactions
- Download to Excel(.xls)
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Johnson & Johnson Innovation - Jjdc, Inc. made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include Chief Development Officer Stephen Machatha , See Remarks Bruce Greenberg , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, Johnson & Johnson Innovation - Jjdc, Inc. made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 57,346 shares made by Stephen Machatha , and a net sale of 37,236 shares made by Bruce Greenberg .
In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,034,319 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,352,054 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .
Genocea Biosciences Inc (GNCAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Universal Biosensors Inc do?
Who are the key executives at Universal Biosensors Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Universal Biosensors Inc. Other key executives at Universal Biosensors Inc include 10 percent owner Vf High Conviction Fund , 10 percent owner Cvc Ltd , and Chief Executive Officer John Stewart Sharman .
Universal Biosensors Inc (UVBIL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Universal Biosensors Inc (UVBIL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Universal Biosensors Inc (UVBIL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Universal Biosensors Inc (UVBIL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Universal Biosensors Inc Insider Transactions
- Download to Excel(.xls)
What does Tengion Inc do?
Who are the key executives at Tengion Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Tengion Inc. Other key executives at Tengion Inc include director & President and CEO John L Miclot , Chf. Fin. Offr & VP Fin. A Brian Davis , and 10 percent owner Medtronic Inc .
Tengion Inc (TNGNQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tengion Inc (TNGNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tengion Inc (TNGNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tengion Inc (TNGNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tengion Inc Insider Transactions
- Download to Excel(.xls)
What does CVRx Inc do?
Who are the key executives at CVRx Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of CVRx Inc. Other key executives at CVRx Inc include Chief Marketing Officer Paul Verrastro , 10 percent owner Johnson & Johnson , and SVP & U.S. Sales Craig E. Palmer .
CVRx Inc (CVRX) Insider Trades Summary
Over the past 18 months, Johnson & Johnson Innovation - Jjdc, Inc. made no insider transaction in CVRx Inc (CVRX). Other recent insider transactions involving CVRx Inc (CVRX) include a net purchase of 8,500 shares made by Joseph P Slattery , a net sale of 4,295 shares made by Paul Verrastro , and a net purchase of 30,000 shares made by Kevin Hykes .
In summary, during the past 3 months, insiders sold 0 shares of CVRx Inc (CVRX) in total and bought 3,000 shares, with a net purchase of 3,000 shares. During the past 18 months, 8,020 shares of CVRx Inc (CVRX) were sold and 38,500 shares were bought by its insiders, resulting in a net purchase of 30,480 shares.
CVRx Inc (CVRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CVRx Inc Insider Transactions
- Download to Excel(.xls)
What does MeiraGTx Holdings PLC do?
Who are the key executives at MeiraGTx Holdings PLC?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of MeiraGTx Holdings PLC. Other key executives at MeiraGTx Holdings PLC include director & 10 percent owner Perceptive Life Sciences Master Fund Ltd , 10 percent owner Johnson & Johnson , and Chief Medical Officer Robert K Zeldin .
MeiraGTx Holdings PLC (MGTX) Insider Trades Summary
Over the past 18 months, Johnson & Johnson Innovation - Jjdc, Inc. made no insider transaction in MeiraGTx Holdings PLC (MGTX). Other recent insider transactions involving MeiraGTx Holdings PLC (MGTX) include a net purchase of 1,250,000 shares made by Perceptive Life Sciences Master Fund Ltd ,
In summary, during the past 3 months, insiders sold 0 shares of MeiraGTx Holdings PLC (MGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MeiraGTx Holdings PLC (MGTX) were sold and 1,250,000 shares were bought by its insiders, resulting in a net purchase of 1,250,000 shares.
MeiraGTx Holdings PLC (MGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MeiraGTx Holdings PLC Insider Transactions
- Download to Excel(.xls)
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Johnson & Johnson Innovation - Jjdc, Inc. is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , EVP PHARM SCI & MFG Stapleton Raymond D Jr , and 10 percent owner Paul Edward Walker .
Genocea Biosciences Inc (GGNNQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
- Download to Excel(.xls)
Johnson & Johnson Innovation - Jjdc, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Johnson & Johnson Innovation - Jjdc, Inc.. You might contact Johnson & Johnson Innovation - Jjdc, Inc. via mailing address: 410 George Street, New Brunswick Nj 08901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
